NCT06628167 2026-03-24
LCS II
Abramson Cancer Center at Penn Medicine
Phase NA Completed
Clinical Trials
7 trialsNCT06560632 2026-01-16
POLAR
Repare Therapeutics
Phase 1 Terminated
NCT02631044 2024-06-27
Study Evaluating the Safety and Pharmacokinetics of JCAR017 in B-cell Non-Hodgkin Lymphoma (TRANSCEND-NHL-001)
Juno Therapeutics, a Subsidiary of Celgene
Phase 1 Completed
NCT04274790 2024-02-14
FLUORIB
Centre Leon Berard
Withdrawn
NCT04763902 2023-11-30
TIMESPAN
University of Utah
Phase NA Completed
NCT04783467 2023-11-30
TREND
University of Utah
Phase NA Unknown
NCT01009073 2017-11-20
A Study Evaluating ABT-263 With Erlotinib, ABT-263 With Irinotecan, and ABT-263 Monotherapy in Cancer Subjects
AbbVie
Phase 1 Completed